Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: How patients with atrial fibrillation (AF) and their clinicians consider cost in forming care plans remains unknown. OBJECTIVE: To identify factors that inform conversations regarding costs of anticoagulants for treatment of AF between patients and clinicians and outcomes associated with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Autores principales: Kamath, Celia C., Giblon, Rachel, Kunneman, Marlene, Lee, Alexander I., Branda, Megan E., Hargraves, Ian G., Sivly, Angela L., Bellolio, Fernanda, Jackson, Elizabeth A., Burnett, Bruce, Gorr, Haeshik, Torres Roldan, Victor D., Spencer-Bonilla, Gabriella, Shah, Nilay D., Noseworthy, Peter A., Montori, Victor M., Brito, Juan P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8278261/
https://ncbi.nlm.nih.gov/pubmed/34255051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.16009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares